Vnitřní lékařství 3/2020

PŘEHLEDOVÉ ČLÁNKY Přehled psychických problémů, které mohou vzniknout při anebo po diagnóze a léčbě maligní choroby | E37  / Vnitř Lék 2020; 66(2): e28–e37  /  VNITŘNÍ LÉKAŘSTVÍ www.casopisvnitrnilekarstvi.cz 10. Kissane DW, Maj M, Sartorius NDepression and Cancer. Wiley Blackwell Oxford 2011; 300s. 11. Maatouk I, He S, Becker N, et al. Association of resilience with health‑related quality of life and depression in multiple myeloma and its precursors: results of a German cross­ ‑sectional study. BMJ Open 2018; 8: e021376. 12. Kiely F, Cran A, Finnerty D, et al. Self‑Reported Quality of Life and Symptom Burden in Ambulatory Patients With Multiple Myeloma on Disease‑Modifying Treatment. Am J Hosp Palliat Care 2017; 34: 671–676. 13. Lamers J, Hartmann M, Goldschmidt H, et al. Psychosocial support in patients with mul- tiple myeloma at time of diagnosis: who wants what? Psychooncology 2013; 22: 2313–2320. 14. Oberoi D, White V, Seymour J, et al. The course of anxiety, depression and unmet needs in survivors of diffuse large B cell lymphoma and multiple myeloma in the early survivor- ship period. J Cancer Surviv 2017; 11: 329-–338. 15. Mols F, Husson O, Roukema JA, et al. Depressive symptoms are a risk factor for all‑cause mortality: results from a prospective population‑based study among 3,080 cancer survi- vors from the PROFILES registry. J Cancer Surviv 2013; 7: 484–492. 16. Niazi S, Frank RD, Sharma M, et al. Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma. Blood Adv 2018; 2: 1120–1128. 17. El‑Jawahri A, Chen YB, Brazauskas R, et al. Impact of pre‑transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation. Ca- ncer 2017; 123: 1828–1838. 18. Svěrák T, Skřivanová K, Anderková Ľ, et al. Screening of psychological distress 4,5 ye- ars after diagnosis in breast cancer patients compared to healthy population Klinická on- kologie 2016; 29: 210–215. 19. Molassiotis A, Wilson B, Blair S, et al. Unmet supportive care needs, psychological well­ ‑being and quality of life in patients living with multiple myeloma and their partners. Psy- chooncology 2011; 20: 88–97. 20. Moghaddam N, Coxon H, Nabarro S, et al. Unmet care needs in people living with advanced cancer: a systematic review. Support Care Cancer 2016; 24: 3609–3622. 21. Bužgová R, Hajnová Fukasová E, Sikorová L et al. Association between unmet needs and quality of life in hospitalised cancer patients no longer receiving anti‑cancer treatment. Eur. J Cancer Care 2014; 23: 685–694. 22. Látalová K, Praško J, Kamarádová D, et al. Posttraumatická stresová porucha. Praktic- ký lékař 2014; 94: 172–176. 23. Mehnert A, Lehmann C, Graefen M, et al. Depression, anxiety, post‑traumatic stress di- sorder and health‑related quality of life and its association with social support in ambula- tory prostate cancer patients. Eur J Cancer Care (Engl) 2010; 19: 736–745. 24. Thekdi SM, Milbury K, Spelman A, et al. Posttraumatic Stress and Depressive Symp- toms in Renal Cell Carcinoma: Association with Quality of Life and Utility of Single Item Distress Screening. Psychooncology 2015; 24: 1477–1484. 25. Geffen DB, Blaustein A. Post‑traumatic stress disorder and quality of life in long‑term survivors of Hodgkin’s disease and non‑Hodgkin’s lymphoma in Israel. Leuk Lympho- ma 2003; 44: 1925–1929. 26. Smith SK, Zimmerman S, Williams CS, et al. Post‑traumatic stress symptoms in long­ ‑term non‑Hodgkin’s lymphoma survivors: does time heal? J Clin Oncol 2011; 29: 4526–4533. 27. Rodin G, Yuen D, Mischitelle A, et al. Traumatic stress in acute leukemia. Psychoonco- logy 2013; 22: 299–307. 28. Jawahri AR, Vandusen HB, Traeger LN, et al. Quality of life and mood predict posttrauma- tic stress disorder after hematopoietic stem cell transplantation. Cancer 2016; 122: 806-812. 29. Avery DH, Shah SH, Eder DN, et al. Nocturnal sweating and temperature in depressi- on. Acta Psychiatr Scand 1999; 100: 295–301. 30. Rietsema WJ. Post‑traumatic stress disorder as a cause of night sweats. Am Fam Phys- ician 2003; 68: 806–808. 31. Mold JW, Holtzclaw BJ, McCarthy L. Night sweats: a systematic review of the literatu- re. J Am Board Fam Med 2012; 25: 878–893. 32. Oka T. Psychogenic fever: how psychological stress affects body temperature in the clinical population. Temperature (Austin) 2015; 2: 368–378. 33. Takakazu O. Psychogenic fever: how psychological stress affects body temperature in the clinical population. Temperature (Austin) 2015; 2: 368–378. 34. Steen R, Dahl AA, Hess SL et al. A study of chronic fatigue in Norwegian cervical can- cer survivors. Gynecol Oncol 2017; 146: 630–635. 35. Nebiker L, Lichtenstein E, Minghetti A, et al. Moderating Effects of Exercise Duration and Intensity in Neuromuscular vs. Endurance Exercise Interventions for the Treatment of Depression: A Meta‑Analytical Review. Front Psychiatry 2018; 9: 305. 36. Rebar RA, Stanton R, Geard D, et al. A meta‑analysis of the effect of physical activi- ty on depression and anxiety in non‑clinical adult populations. Health Psychology Re- view 2015; 9: 366–378. 37. Werneck AO, Oyeyemi AL, Silva Dr. Physical activity and depression: is 150 min/week of moderate to vigorous physical activity a necessary threshold for decreasing risk of de- pression in adults? Different views from the same data. Soc Psychiatry Psychiatr Epide- miol 2018; 53: 323–324. 38. Marker RJ, Cox‑Martin E, Jankowski CM, et al. Evaluation of the effects of a clinically im- plemented exercise program on physical fitness, fatigue, and depression in cancer survi- vors. Support Care Cancer 2018; 26: 1861–1869. 39. Hadrabová M, Janíková A. Význam fyzické aktivity pro přežití a kvalitu života u pa- cientů s lymfoproliferativním onemocněním. Transfuze a Hematologie dnes 2018; 3: 182–193. 40. Janíková A, Radvanský J, Vysoký R, et al. Význam fyzické aktivity u pacientů s hema- toonkologickými malignitami. Transfuze a hematologie dnes 2012; 18: 31–38.